FDAI 80 web
FDA, AI, and the Future of Clinical Trials Why the industry is moving from AI experimentation to AI governance  For the past several years, AI in clinical trials was mostly associated with operational efficiency. The conversation focused on faster recruitment, better analytics, automated workflows, reduced administrative burden, and accelerated study execution.  But over the past month, the FDA started signaling something much bigger. The agency Read more
CRO Poland
CRO in Poland: Why Poland Is Becoming a Core Country for Oncology Clinical Trials in Europe What biotech and pharma sponsors should know about oncology clinical research in Poland By Magda Klosowska, Regional Clinical Manager for Europe at Cromos Pharma When sponsors plan oncology clinical trials in Europe, country selection often defaults to familiar Western European markets, with Central and Eastern Europe treated as a secondary consideration. That mindset deserves reconsideration. Read more
clinical trial trends
World Clinical Trials Day: Clinical Research Is Not Where It Used to Be World Clinical Trials Day is often associated with progress in medicine and the breakthroughs that bring new therapies to patients. Innovation remains at the center of the conversation, but it no longer tells the full story of where the industry stands today.  Clinical research is becoming more complex on every level. Protocols are more demanding, Read more
trump
The US–UK Pharma Deal Is Bigger Than It Looks Key Takeaways The US–UK pharmaceutical agreement may signal a broader shift in how governments view pharma. Drug pricing is increasingly becoming a trade and industrial policy issue, not just a healthcare debate. China’s biotech rise is intensifying the strategic importance of pharmaceutical competitiveness. Future pharma strategy may be shaped as much by geopolitics as by Read more

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us